COMMUNIQUÉS West-GlobeNewswire

Pharming Group to participate in August investor conference
04/08/2025
Leiden, the Netherlands, August 4, 2025: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) announces that Pharming’s management will participate in the following investor conference in the month [...]
EssilorLuxottica: EssilorLuxottica acquires Automation & Robotics, advancing high-performance solutions in ophthalmic manufacturing
04/08/2025
EssilorLuxottica acquires Automation & Robotics, advancing high-performance solutions in ophthalmic manufacturing Paris, France (4 August 2025) – EssilorLuxottica announces today the acquisition of Automation & [...]
EssilorLuxottica: Avec l’acquisition d’Automation & Robotics, EssilorLuxottica progresse dans les solutions de haute performance pour la production en optique ophtalmique
04/08/2025
Avec l’acquisition d’Automation & Robotics, EssilorLuxottica progresse dans les solutions de haute performance pour la production en optique ophtalmique Paris, France (4 août 2025) – EssilorLuxottica a annoncé [...]
AB Science announces the successful completion of a 2.55 million euros private placement
04/08/2025
PRESS RELEASE AB SCIENCE ANNOUNCES THE SUCCESSFUL COMPLETION OF A EUR 2.55 MILLION PRIVATE PLACEMENT Paris, August 4, 2025, 8am CET AB Science S.A. (the “ Company ” or “ AB Science ”, Euronext – FR0010557264 – AB) [...]
AB Science annonce le succès d’un placement privé d’environ 2,55 millions d’euros
04/08/2025
COMMUNIQUE DE PRESSE AB SCIENCE ANNONCE LE SUCCES D’UN PLACEMENT PRIVE D’ENVIRON 2,55 MILLIONS D’EUROS Paris, 4 août 2025, 8h AB Science S.A. (la “ Société ” ou “ AB Science ”, Euronext – FR0010557264 – AB) annonce [...]
Financière de Tubize - 2025 half-year financial report
02/08/2025
Half-year financial report 2025 Regulated information 2 August 2025 The board of directors of Financière de Tubize has established the 2025 half-year report. This report is available on the website www.financiere-tubize [...]
Financière de Tubize - Rapport financier semestriel 2025
02/08/2025
Rapport financier semestriel 2025 Information réglementée - 2 août 2025 Le conseil d’administration de la Financière de Tubize a établi le rapport financier semestriel 2025. Ce rapport est disponible sur le site [...]
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
01/08/2025
DALLAS, Aug. 01, 2025 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies [...]
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01/08/2025
VANCOUVER, British Columbia and BOSTON, Aug. 01, 2025 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to discovering, developing, and delivering [...]
SmartVascular Dx™ Test Elevates Vascular Risk Detection in the Northeast & Partnership with MOMS
01/08/2025
IRVINE, Calif., Aug. 01, 2025 (GLOBE NEWSWIRE) -- MorningStar Laboratories, LLC ., (“MSL” or “the Company”), a leading developer of precision diagnostic tests addressing unmet clinical needs, is excited to announce that [...]
Sirona Biochem Update to Shareholders on Financial Status and Operations
01/08/2025
VANCOUVER, British Columbia, Aug. 01, 2025 (GLOBE NEWSWIRE) -- Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (“Sirona”) wishes to provide shareholders with a critical update on the company’s financial position and recent [...]
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
01/08/2025
SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Aug. 01, 2025 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq:ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of [...]
Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01/08/2025
WALTHAM, Mass., Aug. 01, 2025 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies for people living [...]
ImageneBio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01/08/2025
SAN DIEGO, Aug. 01, 2025 (GLOBE NEWSWIRE) -- ImageneBio, Inc. (Nasdaq: IMA) (“ImageneBio”), a clinical stage biotechnology company dedicated to developing treatments for immunological/autoimmune and inflammatory (“I [...]
Protara Therapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01/08/2025
NEW YORK, Aug. 01, 2025 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA) (“Protara” or the “Company”), a clinical-stage company developing transformative therapies for the treatment of cancer and rare [...]
Information regarding the total number of voting rights and total number of shares of the Company as of July 31, 2025
01/08/2025
Information regarding the total number of voting rights and total number of shares of the Company as of July 31, 2025 (Article 223-16 of the General Regulations of the Autorité des Marchés Financiers ) Market : NYSE [...]
Information relative au nombre total des droits de vote et d’actions composant le capital social au 31 juillet 2025
01/08/2025
Information relative au nombre total des droits de vote et d’actions composant le capital social au 31 juillet 2025 (Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers) Place de cotation : NYSE [...]
Nanox to Report Second Quarter 2025 Financial Results on August 12, 2025
01/08/2025
PETACH TIKVA, Israel, Aug. 01, 2025 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD ("Nanox" or the "Company", Nasdaq: NNOX), an innovative medical imaging technology company, today announced that it will report its financial [...]
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01/08/2025
CAMBRIDGE, Mass., Aug. 01, 2025 (GLOBE NEWSWIRE) -- Akebia Therapeutics ® , Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, granted four newly- [...]

Pages